Hormone replacement therapy in ischemic heart disease prevention in women. Arguments against

被引:1
作者
Alonso, A
Ortigosa, J
Antorrena, I
Castro, A
Toquero, J
Arroyo, R
Conthe, P
机构
[1] Clin Puerta de Hierro, Serv Cardiol, Madrid, Spain
[2] Hosp Gen Gregorio Maranon, Med Interna Serv, Madrid, Spain
来源
REVISTA ESPANOLA DE CARDIOLOGIA | 2001年 / 54卷 / 04期
关键词
coronary disease; women; hormone replacement therapy;
D O I
10.1016/S0300-8932(01)76338-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hormone replacement therapy is one of the most difficult issues women and their doctors face. Epidemiological studies have consistently found that women using hormone replacement therapy are at a substantially lower risk of developing coronary heart disease. Observational data are supported by findings demonstrating that hormone replacement therapy improves several risk factors o coronary heart disease, specially the favourable changes in lipid profile. However, no study has clearly established hormones help prevent heart disease. In women without heart disease, the benefits of hormone replacement therapy are unclear. However, recent clinical trials have sown that the use of hormone replacement therapy does not provide cardiovascular benefits in women with established heart disease.
引用
收藏
页码:499 / 506
页数:8
相关论文
共 14 条
  • [1] Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61
  • [2] CLAIR RS, 1998, AM J CARDIOL, V82, P40
  • [3] Phyto-oestrogens: the way to postmenopausal health?
    Finkel, E
    [J]. LANCET, 1998, 352 (9142) : 1762 - 1762
  • [4] Postmenopausal hormone therapy increases risk for venous thromboembolic disease - The heart and estrogen/progestin replacement study
    Grady, D
    Wenger, NK
    Herrington, D
    Khan, S
    Furberg, C
    Hunninghake, D
    Vittinghoff, E
    Hulley, S
    [J]. ANNALS OF INTERNAL MEDICINE, 2000, 132 (09) : 689 - +
  • [5] Grant C, 1999, LANCET, V354, P152
  • [6] DECREASED MORTALITY IN USERS OF ESTROGEN REPLACEMENT THERAPY
    HENDERSON, BE
    PAGANINIHILL, A
    ROSS, RK
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (01) : 75 - 78
  • [7] Effects of estrogen replacement on the progression of coronary-artery atherosclerosis
    Herrington, DM
    Reboussin, DM
    Brosnihan, KB
    Sharp, PC
    Shumaker, SA
    Snyder, TE
    Furberg, CD
    Kowalchuk, GJ
    Stuckey, TD
    Rogers, WJ
    Givens, DH
    Waters, D
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (08) : 522 - 529
  • [8] Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
    Hulley, S
    Grady, D
    Bush, T
    Furberg, C
    Herrington, D
    Riggs, B
    Vittinghoff, E
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (07): : 605 - 613
  • [9] Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin
    Ross, RK
    Paganini-Hill, A
    Wan, PC
    Pike, MC
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (04): : 328 - 332
  • [10] ASSOCIATION OF EXOGENOUS ESTROGEN AND ENDOMETRIAL CARCINOMA
    SMITH, DC
    PRENTICE, R
    THOMPSON, DJ
    HERRMANN, WL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1975, 293 (23) : 1164 - 1167